| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/01/2009 | US20090005441 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 01/01/2009 | US20090005436 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives |
| 01/01/2009 | US20090005427 Substituted oxadiazole compounds and their use as opioid receptor ligands |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005417 Substituted Indazolyl Sulfonamide and 2,3-Dihydro-Indolyl Sulfonamide Compounds, their Preparation and Use in Medicaments |
| 01/01/2009 | US20090005415 1,2-Diarylimidazoles for Use as Cb1 Modulators |
| 01/01/2009 | US20090005414 Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride Salt |
| 01/01/2009 | US20090005412 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/01/2009 | US20090005407 Particulate (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of its use |
| 01/01/2009 | US20090005402 Medicine containing pyrimidine derivative |
| 01/01/2009 | US20090005399 Substituted Imidazo[2,1-b]thiazole Compounds and Uses Thereof |
| 01/01/2009 | US20090005396 Use of Pyrazolyl-Pyrimidine Derivatives in the Treatment of Pain |
| 01/01/2009 | US20090005390 Novel quinuclidine derivatives and their use |
| 01/01/2009 | US20090005388 3-Heteroaryl-3,9-Diazabicyclo[3.3.1]Nonane Derivatives as Nicotinic Acetylcholine Receptor Agonists |
| 01/01/2009 | US20090005370 Isoxazole-imidazole derivatives |
| 01/01/2009 | US20090005366 Deuterium-enriched olanzapine |
| 01/01/2009 | US20090005365 Therapeutic pyrazolonaphthyridine derivatives |
| 01/01/2009 | US20090005361 Combination of Organic Compounds |
| 01/01/2009 | US20090005360 Modified release preparations containing oxcarbazepine and derivatives thereof |
| 01/01/2009 | US20090005354 New Amino Derivatives and Their Use as Pharmaceuticals |
| 01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
| 01/01/2009 | US20090005352 2,6-(diisopropyl)phenyl 1-[((2S)-2-amino-3-methylbutyryl)aminomethyl]-1-cyclohexane acetate; migraine, nausea, vomiting, anxiety, seizures, convulsions, trauma of the central nervous system, and neurodegenerative conditions of Friedrich's, Parkinson's, Alzheimer's, Huntington's diseases |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005330 Methods and Compositions to Inhibit P2x7 Receptor Expression |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005314 Compositions and Methods for Modulating Pgc-1Alpha to Treat Neurological Diseases and Disorders |
| 01/01/2009 | US20090005313 Activatable clostridial toxins |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005262 Methods, Compositions and Compound Assays for Inhibiting Amyloid-Beta Protein production |
| 01/01/2009 | US20090004689 Lineage Restricted Glial Precursors from the Central Nervous System |
| 01/01/2009 | US20090004299 Methods for Inhibiting a Decline in Learning and/or Memory in Animals |
| 01/01/2009 | US20090004291 Compositions and methods for treating alzheimer's disease and dementia |
| 01/01/2009 | US20090004281 Multiparticulate osmotic delivery system |
| 01/01/2009 | US20090004270 Method of using guava extract |
| 01/01/2009 | US20090004257 Transdermal administration of fentanyl and analogs thereof |
| 01/01/2009 | US20090004249 Dual release nicotine formulations, and systems and methods for their use |
| 01/01/2009 | US20090004238 Implantation of encapsulated biological materials for treating diseases |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004224 Activatable clostridial toxins |
| 01/01/2009 | US20090004209 4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004166 Carrier For Enternal Administration |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004144 Recombinant Adeno-Associated Virus Vector for Treatment of Alzheimer Disease |
| 01/01/2009 | US20090004112 Methods for the treatment of neurodegenerative diseases using nmda receptor glycine site antagonists |
| 01/01/2009 | US20090004107 Beta-amyloid and neurofibrillary tangle imaging agents |
| 12/31/2008 | WO2009003061A1 Methods and compositions regarding polychalcogenide compositions |
| 12/31/2008 | WO2009002977A1 Salacia cuspidata extract and methods of extracting and using such extract |
| 12/31/2008 | WO2009002970A1 Compositions comprising tryptophan hydroxylase inhibitors |
| 12/31/2008 | WO2009002802A2 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/31/2008 | WO2009002423A2 Polycyclic guanine derivatives and use thereof |
| 12/31/2008 | WO2009002166A1 Improving memory in subjects with mini-mental state examination of 24-26 |
| 12/31/2008 | WO2009002148A1 Food composition for prodromal dementia patients |
| 12/31/2008 | WO2009002146A1 Supporting activities of daily living |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001764A1 Remedy or preventive for integration dysfunction syndrome |
| 12/31/2008 | WO2009001730A1 Novel compound having β secretase inhibitory activity |
| 12/31/2008 | WO2009001661A1 Medicinal agent for prevention or treatment of alzheimer's disease |
| 12/31/2008 | WO2009001356A2 Acyl-urea derivatives and uses thereof |
| 12/31/2008 | WO2009001146A1 Pharmaceutical composition containing acetylcholine esterase inhibitor and method for the preparation thereof |
| 12/31/2008 | WO2009001081A1 Therapeutic uses of cannabigerol |
| 12/31/2008 | WO2009001046A2 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use |
| 12/31/2008 | WO2009001043A2 Duloxetine formulation |
| 12/31/2008 | WO2009001040A2 Treatment of depression |
| 12/31/2008 | WO2009000926A1 Combinations of sap depleting agents and anti-sap antibodies |
| 12/31/2008 | WO2009000819A1 5-phenyl-1,3,4-oxadiazol-2-yl-acetyl-4-piperidinyl derivatives as cgrp receptor antagonists |
| 12/31/2008 | WO2009000797A1 N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs |
| 12/31/2008 | WO2009000662A1 Isoxazole-imidazole derivatives |
| 12/31/2008 | WO2009000558A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | WO2009000406A1 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2009000145A1 Use and preparation of paeoniflorin and the composition thereof |
| 12/31/2008 | WO2009000038A1 Combination methods and compositions for treatment of neuropathic pain |
| 12/31/2008 | WO2008141097A3 Stereoisomers propofol therapeutic compounds |
| 12/31/2008 | WO2008127399A3 Azaindole derivatives as cftr modulators |
| 12/31/2008 | WO2008117269A3 Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof |
| 12/31/2008 | WO2008117241A3 Thiazolidine derivatives as orexin receptor antagonists |
| 12/31/2008 | WO2008116648A3 Novel glp-1 fusion peptides, their production and use |
| 12/31/2008 | WO2008116024A3 Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
| 12/31/2008 | WO2008098151A3 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same |
| 12/31/2008 | WO2008060375A3 Upregulating bdnf levels to mitigate mental retardation |
| 12/31/2008 | WO2008021394A3 Pharmaceutical formulations of cannabinoids and method of use |
| 12/31/2008 | WO2006078753B1 N-substituted heterocyclic sulfonamides |
| 12/31/2008 | WO2006078753A4 N-substituted heterocyclic sulfonamides |
| 12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 12/31/2008 | EP2009006A1 Ureide derivative and use thereof for medical purposes |
| 12/31/2008 | EP2009000A1 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 12/31/2008 | EP2008994A1 New crystalline form IV of agomelatine, method of preparing same and pharmaceutical compositions containing same |
| 12/31/2008 | EP2008993A1 New crystalline form III of agomelatine, method of preparing same and pharmaceutical compositions containing same |
| 12/31/2008 | EP2008658A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2008653A1 Serotonergic compounds for treating neuronal illnesses |
| 12/31/2008 | EP2008650A2 Solid oral composition comprising a S 1 P receptor agonist and a sugar alcohol |
| 12/31/2008 | EP2008649A1 Spill resistant pharmaceutical compositions |
| 12/31/2008 | EP2007880A2 Survival and development of neural cells |
| 12/31/2008 | EP2007753A1 Heterocyclic gaba alpha subtype selective receptor modulators |
| 12/31/2008 | EP2007751A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
| 12/31/2008 | EP2007750A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors |
| 12/31/2008 | EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |